Publications (42) María Iraburu Elizalde publications

filter_list

2023

  1. Antifibrogenic and apoptotic effects of Ocoxin in cultured rat hepatic stellate cells

    Journal of Physiology and Biochemistry, Vol. 79, Núm. 4, pp. 881-890

  2. Sostenibilidad: una mirada esperanzada

    Nuestro tiempo, Núm. 717

2022

  1. Activation of the unfolded protein response (Upr) is associated with cholangiocellular injury, fibrosis and carcinogenesis in an experimental model of fibropolycystic liver disease

    Cancers, Vol. 14, Núm. 1

  2. Messenger RNA as a personalized therapy: The moment of truth for rare metabolic diseases

    International Review of Cell and Molecular Biology (Elsevier Inc.), pp. 55-96

  3. New molecular mechanisms in cholangiocarcinoma: signals triggering interleukin-6 production in tumor cells and KRAS co-opted epigenetic mediators driving metabolic reprogramming

    Journal of Experimental and Clinical Cancer Research, Vol. 41, Núm. 1

2021

  1. Dual Targeting of G9a and DNA Methyltransferase-1 for the Treatment of Experimental Cholangiocarcinoma

    Hepatology, Vol. 73, Núm. 6, pp. 2380-2396

  2. El estudiante como centro de la actividad universitaria

    Lecturas de política y gestión universitarias (Thomson Reuters Aranzadi), pp. 331-356

  3. Epigenetic mechanisms and metabolic reprogramming in fibrogenesis: Dual targeting of G9a and DNMT1 for the inhibition of liver fibrosis

    Gut, Vol. 70, Núm. 2, pp. 388-400

  4. Revising endosomal trafficking under insulin receptor activation

    International Journal of Molecular Sciences, Vol. 22, Núm. 13

2020

  1. AGAP2: Modulating TGFβ1-signaling in the regulation of liver fibrosis

    International Journal of Molecular Sciences, Vol. 21, Núm. 4

  2. Pilot multi-omic analysis of human bile from benign and malignant biliary strictures: A machine-learning approach

    Cancers, Vol. 12, Núm. 6, pp. 1-30

2019

  1. Dual Targeting of Histone Methyltransferase G9a and DNA-Methyltransferase 1 for the Treatment of Experimental Hepatocellular Carcinoma

    Hepatology, Vol. 69, Núm. 2, pp. 587-603

  2. Role of AGAP2 in the profibrogenic effects induced by TGFβ in LX-2 hepatic stellate cells

    Biochimica et Biophysica Acta - Molecular Cell Research, Vol. 1866, Núm. 4, pp. 673-685

2018

  1. NADPH oxidase 5 promotes proliferation and fibrosis in human hepatic stellate cells

    Free Radical Biology and Medicine, Vol. 126, pp. 15-26

2016

  1. La encíclica Laudato si' y la universidad: una llamada y un reto

    Cuidar la creación: estudios sobre la encíclica "Laudato si'" (EUNSA. Ediciones Universidad de Navarra, S.A.), pp. 21-40

  2. Unfolded protein response induced by Brefeldin A increases collagen type I levels in hepatic stellate cells through an IRE1α, p38 MAPK and Smad-dependent pathway

    Biochimica et Biophysica Acta - Molecular Cell Research, Vol. 1863, Núm. 8, pp. 2115-2123

2015

  1. Fibronectin peptides as potential regulators of hepatic fibrosis through apoptosis of hepatic stellate cells

    Journal of Cellular Physiology, Vol. 230, Núm. 3, pp. 546-553

  2. Oxidation pathways underlying the pro-oxidant effects of apigenin

    Free Radical Biology and Medicine, Vol. 87, pp. 169-180

2013

  1. GCN2 kinase is a key regulator of fibrogenesis and acute and chronic liver injury induced by carbon tetrachloride in mice

    Laboratory Investigation, Vol. 93, Núm. 3, pp. 303-310

2011

  1. Apoptosis of hepatic stellate cells mediated by specific protein nitration

    Biochemical Pharmacology, Vol. 81, Núm. 3, pp. 451-458